Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival

Background: A higher rate of cancer in systemic sclerosis (SSc) is recognized but the role of SSc-linked autoantibodies status (positive/negative and autoantibody specificities) in the survival of SSc-patients with cancer remains poorly understood. Methods: We utilized the Clalit-Health-Services med...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abdulla Watad, Dennis McGonagle, Nicola L. Bragazzi, Shmuel Tiosano, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen, Howard Amital
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis Group 2019-06-01
Col·lecció:OncoImmunology
Matèries:
systemic sclerosis
scleroderma
malignancy
cancer
autoantibodies
autoimmune diseases
Accés en línia:http://dx.doi.org/10.1080/2162402X.2019.1588084
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars